We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

How Can We Take Advantage of Ketamine’s “Window of Opportunity?”

Article   Apr 21, 2021

 
How Can We Take Advantage of Ketamine’s “Window of Opportunity?”

The Janssen-branded drug Spravato® (Esketamine) was approved by the US Food and Drug Administration in 2019.

Ruairi J Mackenzie

Senior Science Writer

@rjmsci

 
 
Advertisement
 

RELATED ARTICLES

LC-MS - What Is LC-MS, LC-MS Analysis and LC-MS/MS

Article

Coupling liquid chromatography (LC) with mass spectrometry (MS) has provided scientists with a powerful tool to meet stringent analytical demands and their versatility and efficiency means LC-MS instruments have become desirable in many laboratories. In this article, we consider how LC-MS works, what it tells us and highlight some if the techniques strengths and weaknesses.

READ MORE

Three Psychology Experiments That Pushed the Limit of Ethics

Article

We examine three studies that psuhed the limits of what experimental scientists can consider ethical in the wake of the Deep Time experiment's conclusion.

READ MORE

Toxicity Studies in Vaccine Clinical Development and Registration

Article

Before the safety and efficacy of a new vaccine can be evaluated in a Phase I clinical trial with human subjects, it must first undergo non-clinical safety evaluation in animal models. This article explores the full process.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE